Momenta Pharmaceuticals CEO Craig Wheeler's 2019 pay stays at $4.6M
Momenta Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Momenta Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Momenta Pharmaceuticals received on average a compensation package of $2M, a 20% decrease compared to previous year.
Average pay of disclosed executives at Momenta Pharmaceuticals
Craig A. Wheeler, Chief Executive Officer, received $4.6M in total, which is about the same as previous year. 69% of Wheeler's compensation, or $3.2M, was in option awards. Wheeler also received $630K in non-equity incentive plan, $750K in salary, as well as $30K in other compensation.
For fiscal year 2019, the median employee pay was $210,742 at Momenta Pharmaceuticals. Therefore, the ratio of Craig A. Wheeler's pay to the median employee pay was 22 to one.
Young Kwon, Chief Business Officer, received a compensation package of $1.5M, which decreased by 36% compared to previous year. 58% of the compensation package, or $874K, was in option awards.
Santiago Arroyo, Chief Medical Officer, earned $1.5M in 2019, a 35% decrease compared to previous year.
Anthony Manning, Chief Scientific Officer, received $1.2M in 2019, which decreases by 43% compared to 2018.
Michelle Robertson, Chief Financial Officer, earned $992K in 2019, a 18% decrease compared to previous year.
Related executives
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
Michelle Robertson
Momenta Pharmaceuticals
Chief Financial Officer
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
Young Kwon
Momenta Pharmaceuticals
Chief Business Officer
Anthony Manning
Momenta Pharmaceuticals
Chief Scientific Officer
You may also like
Source: SEC filing on April 24, 2020.